Soru

Zorluk: ZorBreast and Endocrine Surgery

A 3131-year-old man comes to the physician for evaluation of a painless neck mass he noticed while shaving two weeks ago. For the past four months, he has experienced episodic, severe headaches accompanied by profound sweating and palpitations, which he attributed to work-related stress. His blood pressure is 172/98172/98 mm Hg, and his pulse is 108108/min. Physical examination reveals a 2.52.5-cm, firm, mobile, non-tender mass in the right anterior neck. Laboratory studies show a serum thyroid-stimulating hormone (TSH) level of 6.26.2 μ\mu U/mL (normal: 0.40.4–4.04.0 μ\mu U/mL) and a free thyroxine (T4) level of 1.11.1 ng/dL (normal: 0.90.9–2.42.4 ng/dL). An ultrasound of the neck demonstrates a 2.32.3-cm solid, hypoechoic nodule with microcalcifications in the right thyroid lobe. Fine-needle aspiration biopsy of the nodule reveals clusters of spindle-shaped cells with pleomorphic nuclei and extracellular deposits that demonstrate apple-green birefringence under polarized light after Congo red staining. Which of the following is the most appropriate next step in the management of this patient?

  1. Evaluation of plasma free metanephrine levelsCevap
  2. B
    Commencement of daily levothyroxine therapy
  3. C
    Administration of a nonselective beta-adrenergic antagonist
  4. D
    Bilateral excision of the thyroid gland
  5. E
    Iodine-131 radionuclide whole-body scintigraphy

Cevap

The most appropriate next step is the evaluation of plasma free metanephrine levels to rule out a coexisting pheochromocytoma.
The correct action is to evaluate plasma free metanephrines. This patient's biopsy showing Congo red-positive amyloid deposits and spindle cells confirms medullary thyroid carcinoma (MTC). MTC is frequently associated with Multiple Endocrine Neoplasia type 2 (MEN2), which includes pheochromocytomas. The patient's episodic headaches, sweating, tachycardia, and hypertension are classic signs of a pheochromocytoma. In any patient diagnosed with MTC, a pheochromocytoma MUST be biochemically ruled out (using plasma free metanephrines or 24-hour urine metanephrines and catecholamines) before proceeding with any surgical intervention, including thyroidectomy. Induction of anesthesia or surgical manipulation in an unblocked patient with a pheochromocytoma can precipitate a massive, potentially fatal hypertensive crisis.

Adım Adım Çözüm

1
Interpret the biopsy findings.
Spindle-shaped cells with Congo red-positive extracellular deposits (amyloid) confirm the diagnosis of medullary thyroid carcinoma (MTC).
MTC is characterized by malignant parafollicular C cells that secrete calcitonin, which deposits as amyloid in the surrounding tissue.
2
Correlate the diagnosis with the patient's systemic symptoms.
The combination of MTC and episodic headaches, diaphoresis, tachycardia, and hypertension is highly suspicious for Multiple Endocrine Neoplasia type 2A or 2B (MEN2A/2B).
MEN2 syndromes are characterized by the presence of MTC and pheochromocytoma (a catecholamine-secreting tumor of the adrenal medulla).
3
Determine the optimal preoperative sequence for a patient with suspected MEN2.
Biochemical testing for a pheochromocytoma (via plasma free metanephrines or 24-hour urine metanephrines) must be performed.
If a patient with an undiagnosed and unblocked pheochromocytoma undergoes general anesthesia and surgery (e.g., thyroidectomy), the stress can trigger a massive release of catecholamines, leading to a fatal hypertensive crisis.

Anahtar Kavram

Preoperative evaluation of medullary thyroid carcinoma requires mandatory biochemical screening for a coexisting pheochromocytoma (MEN2) to prevent life-threatening intraoperative hypertensive crisis.

Alternatif Yöntem

Measurement of 24-hour urinary fractionated metanephrines and catecholamines is an equally valid initial screening test for pheochromocytoma.
Tahmini Süre:1m 30s
Bu soruyu puanla